Sentiss Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENTISS, and what generic and branded alternatives to SENTISS drugs are available?
SENTISS has twelve approved drugs.
Drugs and US Patents for Sentiss
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sentiss Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217195-001 | May 8, 2023 | AT3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 215933-001 | Apr 12, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | BROMFENAC SODIUM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203395-001 | Jan 22, 2014 | AT2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 207609-001 | Apr 17, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 074543-001 | Jan 15, 1998 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | GEL;OPHTHALMIC | 212080-001 | Feb 10, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sentiss | ERYTHROMYCIN | erythromycin | OINTMENT;OPHTHALMIC | 064030-001 | Jul 18, 1996 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.